The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation between radiographic progression-free survival (rPFS) and overall survival (OS): Results from PREVAIL.
 
Michael J. Morris
Consulting or Advisory Role - Astellas Pharma; Bayer; Millennium; Progenics
Research Funding - Agensys (Inst); Bayer (Inst); Janssen Oncology (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - fujifilm
 
Tomasz M. Beer
Stock and Other Ownership Interests - Salarius Pharmaceuticals
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Novartis; Sotio
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Research & Development (Inst); Medivation (Inst); OncoGenex (Inst); Sotio (Inst)
 
Yohann Loriot
Honoraria - Astellas Pharma; Bayer; Ipsen; Janssen; OncoGenex; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer
Travel, Accommodations, Expenses - Astellas Pharma; Sanofi
 
Celestia S. Higano
Employment - Cell Therapeutics (I)
Leadership - Cell Therapeutics (I)
Stock and Other Ownership Interests - Cell Therapeutics (I)
Consulting or Advisory Role - AbbVie; Bayer; BHR Pharma; Dendreon; Emergent BioSolutions; Ferring; Genentech; Medivation; Orion; Pfizer; Sanofi
Research Funding - Algeta/Bayer (Inst); Aragon Pharmaceuticals (Inst); AstraZeneca (Inst); Dendreon (Inst); Emergent BioSolutions (Inst); Exelixis (Inst); Genentech (Inst); Medivation (Inst); Millennium (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst)
Travel, Accommodations, Expenses - AbbVie; Amgen; Astellas Pharma; Bayer; Dendreon; Emergent BioSolutions; Ferring; Genentech; Johnson & Johnson; Medivation; Ockham; Orion; Pfizer; Sanofi; Teva
 
Andrew J. Armstrong
Honoraria - Dendreon; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; Janssen Biotech; Medivation; Novartis; Sanofi
Speakers' Bureau - Dendreon
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); ImClone Systems (Inst); Janssen Oncology (Inst); KangLaiTe (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Dendreon; Janssen Biotech; Medivation
 
Cora N. Sternberg
Honoraria - Argos Therapeutics; Astellas Pharma; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; Janssen; Lilly/ImClone; Merck; Millennium; Novartis; Oncogenex; Pfizer; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Bayer; Novartis
 
Johann S. De Bono
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Genentech/Roche; Sanofi
Research Funding - AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Genmab; GlaxoSmithKline; Orion; Qiagen; Sanofi; Taiho Pharmaceutical; Vertex
 
Bertrand F. TOMBAL
Leadership - Amgen; Bayer; Ferring; Sanofi
Honoraria - Astellas Pharma; Medivation
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Ferring; Medivation
Speakers' Bureau - Amgen; Bayer; Ferring; Sanofi
 
Teresa Parli
Employment - Medivation
 
Suman Bhattacharya
Employment - Medivation
 
Andrew P. Krivoshik
Employment - Astellas Pharma
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Johnson & Johnson (I); Merck (I)
Patents, Royalties, Other Intellectual Property - U.S. Patent Application 20090149461 11 June 2009 Method of Treating Cancer (U.S. Provisional Application Ser. No. 61/058,113, filed Jun. 2, 2008; U.S. Provisional Application Ser. No. 60/992,857, filed Dec. 6, 2007). European Patent Office Application 08 (Inst)
Travel, Accommodations, Expenses - Astellas Pharma
 
De Phung
Employment - Astellas Pharma
 
Dana E. Rathkopf
Consulting or Advisory Role - Janssen Oncology
Research Funding - Celgene (Inst); Ferring (Inst); Janssen Oncology (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); Takeda (Inst)